COST-EFFECTIVENESS ANALYSIS OF USING KETOANALOGUES OF ESSENTIAL AMINOACIDS IN PATIENTS WITH CHRONIC KIDNEY DISEASE IN KAZAKHSTAN

被引：0
|
作者：
Avdeyev, A. [1 ]
Gulyaev, A. [2 ]
Akhmedullin, R. [3 ]
机构：
[1] Med Ctr Hosp Presidents Affairs Adm Republ Kazakh, Nur Sultan, AKM, Kazakhstan
[2] Nazarbayev Univ, Astana, Kazakhstan
[3] Med Ctr Hosp Presidents Affairs Adm Republ Kazakh, Astana, AKM, Kazakhstan
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE115
引用
收藏
页码：S73 / S73
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness of epoetin alfa in patients on chronic kidney dialysis
    Hollenbeak, Christopher
    Davies, Andrew
    McClellan, William M.
    de Lissovoy, Gregory
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (04) : A45 - A45
  • [32] Cost-Effectiveness Analysis of a Randomized Trial Comparing Care Models for Chronic Kidney Disease
    Hopkins, Robert B.
    Garg, Amit X.
    Levin, Adeera
    Molzahn, Anita
    Rigatto, Claudio
    Singer, Joel
    Soltys, George
    Soroka, Steven
    Parfrey, Patrick S.
    Barrett, Brendan J.
    Goeree, Ron
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (06): : 1248 - 1257
  • [33] Cost-Effectiveness Analysis for the Treatment of Chronic Kidney Disease with Low-Protein Diet
    Mennini, F. S.
    Russo, S.
    Marcellusi, A.
    Palazzo, F.
    Quintaliani, P.
    FUNCTIONAL FOODS IN HEALTH AND DISEASE, 2013, 3 (07): : 291 - +
  • [34] COST-EFFECTIVENESS ANALYSIS OF PEGMOLESATIDE COMPARED TO DARBEPOETIN IN PATIENTS WITH ANEMIA CAUSED BY CHRONIC KIDNEY DISEASE: THE CASE OF CHINA
    Zhang, P.
    Chen, X.
    Chen, W.
    VALUE IN HEALTH, 2024, 27 (06) : S72 - S72
  • [35] A cost-effectiveness analysis of patiromer for the treatment of hyperkalemia in chronic kidney disease patients with and without heart failure in Spain
    Ramon Gonzalez-Juanatey, Jose
    Gonzalez-Franco, Alvaro
    de Sequera, Patricia
    Valls, Marta
    Ramirez de Arellano, Antonio
    Pomares, Elisenda
    Nieves, Diana
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 640 - 649
  • [36] A cost-effectiveness analysis of the Chronic Disease Management Program in patients with hypertension in Korea
    Kim, Woorim
    Lee, Sang Ah
    Chun, Sung-Youn
    INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 2021, 33 (02)
  • [37] A cost-effectiveness analysis of lusutrombopag for thrombocytopenia in patients with chronic liver disease in Japan
    Miki, Norikane
    Inoue, Sachie
    Shibahara, Hidetoshi
    Kurazono, Kenji
    Perard, Rodolphe
    Tateishi, Ryosuke
    JGH OPEN, 2021, 5 (08): : 879 - 887
  • [38] Cost-Effectiveness of Statins for Primary Cardiovascular Prevention in Chronic Kidney Disease
    Erickson, Kevin F.
    Japa, Sohan
    Owens, Douglas K.
    Chertow, Glenn M.
    Garber, Alan M.
    Goldhaber-Fiebert, Jeremy D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (12) : 1250 - 1258
  • [39] Cost-effectiveness of chronic kidney disease mass screening test in Japan
    Kondo, Masahide
    Yamagata, Kunihiro
    Hoshi, Shu-Ling
    Saito, Chie
    Asahi, Koichi
    Moriyama, Toshiki
    Tsuruya, Kazuhiko
    Yoshida, Hideaki
    Iseki, Kunitoshi
    Watanabe, Tsuyoshi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2012, 16 (02) : 279 - 291
  • [40] Cost-Effectiveness of Dapagliflozin for Non-diabetic Chronic Kidney Disease
    Tisdale, Rebecca L.
    Cusick, Marika M.
    Aluri, Kelly Zhang
    Handley, Thomas J.
    Joyner, Alice Kate Cummings
    Salomon, Joshua A.
    Chertow, Glenn M.
    Goldhaber-Fiebert, Jeremy D.
    Owens, Douglas K.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2022, 37 (13) : 3380 - 3387
12345